Pharma News Articles

▼ Show details

MDLinx Pharma helps physicians and healthcare professionals stay up to date with the latest pharma news articles and research, as well as pharma jobs, conferences, and resources.

Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Teva announces U.S. Supreme Court decision to reverse federal circuit courts judgment on copaxone 20 mg/ml case and remand for further review Full Text Teva Pharmaceutical Industries, January 23, 2015

2 OFEV (nintedanib) approved in the EU for the treatment of IPF Full Text Boehringer Ingelheim, January 23, 2015

3 Valeant announces launch of private offering of senior notes Full Text Valeant Pharmaceuticals International, January 23, 2015

4 Daiichi Sankyo, Inc. announces Civil Settlement Full Text Daiichi Sankyo, January 23, 2015

5 Real-world data published in clinical cardiology show consistent safety performance of once-daily XARELTO Full Text Janssen, January 23, 2015

6 Ex UPMC CIO Drawbaugh to lead Steadman Clinic Healthcare Informatics, January 23, 2015

7 Bausch + lomb introduces new software and advanced OCT imaging system for VICTUS femtosecond laser platform Full Text Valeant Pharmaceuticals International, January 23, 2015

8 FDA grants priority review for three-month paliperidone palmitate for the treatment of schizophrenia Full Text Janssen, January 23, 2015

9 PEGASUS-TIMI 54 study of BRILINTA meets primary endpoint in both 60mg and 90mg doses Full Text AstraZeneca, January 23, 2015

10 Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need Full Text Roche, January 23, 2015

11 Valeant announces pricing of private offering of senior notes Full Text Valeant Pharmaceuticals International, January 23, 2015

12 Teva to report fourth quarter 2014 financial results on February 5, 2015 Full Text Teva Pharmaceutical Industries, January 23, 2015

13 Preoperative carboplatin–paclitaxel–bevacizumab in triple-negative breast cancer: final results of the Phase II Ca.Pa.Be Study Annals of Surgical Oncology, January 23, 2015    Clinical Article

14 National trends of 3- versus 2-stage restorative proctocolectomy for chronic ulcerative colitis Diseases of the Colon and Rectum, January 23, 2015    Review Article

15 Merck completes tender offer to acquire Cubist Full Text Merck, January 23, 2015

16 Marketing authorisation application for gout treatment lesinurad accepted by European Medicines Agency Full Text AstraZeneca, January 23, 2015

17 Health care burden of anterior cervical spine surgery: national trends in hospital charges and length of stay, 2000–2009 Journal of Spinal Disorders & Techniques, January 23, 2015    Evidence Based Medicine    Clinical Article

18 Boehringer Ingelheim and Sanofi enter into a strategic contract manufacturing alliance to produce biopharmaceuticals Full Text Boehringer Ingelheim, January 23, 2015

19 Can we use social media to support content validity of patient-reported outcome instruments in medical product development? Value in Health, January 23, 2015    Review Article

20 Boehringer Ingelheim and Vanderbilt University join forces to develop new Ras inhibitors for cancer treatment Full Text Boehringer Ingelheim, January 23, 2015

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Pharma News

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List